<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37628709</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1658</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes14081658</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal dementia (FDT) are progressive neurodegenerative disorders that, in several cases, overlap in clinical presentation, and genetic and pathological disease mechanisms. About 10-15% of ALS cases and up to 40% of FTD are familial, usually with dominant traits. ALS and FTD, in several cases, share common gene mutations, such as in <i>C9ORF72</i>, <i>TARDBP</i>, <i>SQSTM-1</i>, <i>FUS</i>, <i>VCP</i>, <i>CHCHD10</i>, and <i>TBK-1</i>. Also, several mechanisms are involved in ALS and FTD pathogenesis, such as protein misfolding, oxidative stress, and impaired axonal transport. In addition, neuroinflammation and neuroinflammatory cells, such as astrocytes, oligodendrocytes, microglia, and lymphocytes and, overall, the cellular microenvironment, have been proposed as pivotal players in the pathogenesis the ALS-FTD spectrum disorders. This review overviews the current evidence regarding neuroinflammatory markers in the ALS/FTD continuum, focusing on the neuroinflammatory pathways involved in the genetic cases, moving from post-mortem reports to in vivo biofluid and neuroimaging data. We further discuss the potential link between genetic and autoimmune disorders and potential therapeutic implications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Marchi</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0197-1880</Identifier><AffiliationInfo><Affiliation>ALS Center, Neurology Unit, Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tondo</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0057-3103</Identifier><AffiliationInfo><Affiliation>Neurology Unit, Department of Translational Medicine, S. Andrea Hospital, University of Piemonte Orientale, 13100 Vercelli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corrado</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Eastern Piedmont, 28100 Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menegon</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0005-2432-2762</Identifier><AffiliationInfo><Affiliation>Neurology Unit, Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aprile</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Translational Medicine, S. Andrea Hospital, University of Piemonte Orientale, 13100 Vercelli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anselmi</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Alfonso</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Eastern Piedmont, 28100 Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comi</LastName><ForeName>Cristoforo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6862-9468</Identifier><AffiliationInfo><Affiliation>Neurology Unit, Department of Translational Medicine, S. Andrea Hospital, University of Piemonte Orientale, 13100 Vercelli, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), University of Piemonte Orientale, 28100 Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzini</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ALS Center, Neurology Unit, Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554426">CHCHD10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">autoimmune</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">genetic</Keyword><Keyword MajorTopicYN="N">immune system</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">therapy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>7</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37628709</ArticleId><ArticleId IdType="pmc">PMC10454262</ArticleId><ArticleId IdType="doi">10.3390/genes14081658</ArticleId><ArticleId IdType="pii">genes14081658</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman E.L., Goutman S.A., Petri S., Mazzini L., Savelieff M.G., Shaw P.J., Sobue G. Amyotrophic Lateral Sclerosis. Lancet. 2022;400:1363&#x2013;1380. doi: 10.1016/S0140-6736(22)01272-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01272-7</ArticleId><ArticleId IdType="pmc">PMC10089700</ArticleId><ArticleId IdType="pubmed">36116464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Mora G., Moglia C., Manera U., Canosa A., Cammarosano S., Ilardi A., Bertuzzo D., Bersano E., Cugnasco P. Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d&#x2019;Aosta Register. JAMA Neurol. 2017;74:1097&#x2013;1104. doi: 10.1001/jamaneurol.2017.1387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.1387</ArticleId><ArticleId IdType="pmc">PMC5710181</ArticleId><ArticleId IdType="pubmed">28692730</ArticleId></ArticleIdList></Reference><Reference><Citation>Tondo G., De Marchi F. From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We? J. Clin. Med. 2022;11:4515. doi: 10.3390/jcm11154515.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154515</ArticleId><ArticleId IdType="pmc">PMC9369634</ArticleId><ArticleId IdType="pubmed">35956130</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignaroli F., Mele A., Tondo G., De Giorgis V., Manfredi M., Comi C., Mazzini L., De Marchi F. The Need for Biomarkers in the ALS&#x2013;FTD Spectrum: A Clinical Point of View on the Role of Proteomics. Proteomes. 2023;11:1. doi: 10.3390/proteomes11010001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/proteomes11010001</ArticleId><ArticleId IdType="pmc">PMC9844364</ArticleId><ArticleId IdType="pubmed">36648959</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang J., Spina S., Miller B.L. Non-Alzheimer&#x2019;s Dementia 1: Frontotemporal Dementia. Lancet. 2015;386:1672. doi: 10.1016/S0140-6736(15)00461-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00461-4</ArticleId><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney N.T., Spina S., Miller B.L. Frontotemporal Dementia. Neurol. Clin. 2017;35:339&#x2013;374. doi: 10.1016/j.ncl.2017.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2017.01.008</ArticleId><ArticleId IdType="pmc">PMC5472209</ArticleId><ArticleId IdType="pubmed">28410663</ArticleId></ArticleIdList></Reference><Reference><Citation>Tondo G., De Marchi F., Terazzi E., Sacchetti M., Cantello R. Frontotemporal Dementia Presenting as Gambling Disorder: When a Psychiatric Condition Is the Clue to a Neurodegenerative Disease. Cogn. Behav. Neurol. 2017;30:62&#x2013;67. doi: 10.1097/WNN.0000000000000122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNN.0000000000000122</ArticleId><ArticleId IdType="pubmed">28632523</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K., Grossman M. Clinical Diagnostic Criteria and Classification Controversies in Frontotemporal Lobar Degeneration. Int. Rev. Psychiatry. 2013;25:145&#x2013;158. doi: 10.3109/09540261.2013.763341.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09540261.2013.763341</ArticleId><ArticleId IdType="pmc">PMC3906583</ArticleId><ArticleId IdType="pubmed">23611345</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K., Hodges J.R., Knopman D., Mendez M.F., Kramer J.H., Neuhaus J., Van Swieten J.C., Seelaar H., Dopper E.G.P., Onyike C.U. Sensitivity of Revised Diagnostic Criteria for the Behavioural Variant of Frontotemporal Dementia. Brain. 2011;134:2456&#x2013;2477. doi: 10.1093/brain/awr179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Liljegren M., Naasan G., Temlett J., Perry D.C., Rankin K.P., Merrilees J., Grinberg L.T., Seeley W.W., Englund E., Miller B.L. Criminal Behavior in Frontotemporal Dementia and Alzheimer Disease. JAMA Neurol. 2015;72:295&#x2013;300. doi: 10.1001/jamaneurol.2014.3781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.3781</ArticleId><ArticleId IdType="pmc">PMC4432918</ArticleId><ArticleId IdType="pubmed">25559744</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A., Padovani A., Borroni B. Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. Front. Aging Neurosci. 2015;7:171. doi: 10.3389/fnagi.2015.00171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00171</ArticleId><ArticleId IdType="pmc">PMC4555036</ArticleId><ArticleId IdType="pubmed">26388768</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell J.R., Halliday G.M., Kril J.J., Ittner L.M., G&#xf6;tz J., Kiernan M.C., Hodges J.R. The Frontotemporal Dementia-Motor Neuron Disease Continuum. Lancet. 2016;388:919&#x2013;931. doi: 10.1016/S0140-6736(16)00737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F., Tondo G., Sarnelli M.F., Corrado L., Solara V., D&#x2019;Alfonso S., Cantello R., Mazzini L. A Case of Progressive Non-Fluent Aphasia as Onset of Amyotrophic Lateral Sclerosis with Frontotemporal Dementia. Int. J. Neurosci. 2019;129:719&#x2013;721. doi: 10.1080/00207454.2018.1516657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207454.2018.1516657</ArticleId><ArticleId IdType="pubmed">30146930</ArticleId></ArticleIdList></Reference><Reference><Citation>Olszewska D.A., Lonergan R., Fallon E.M., Lynch T. Genetics of Frontotemporal Dementia. Curr. Neurol. Neurosci. Rep. 2016;16:1&#x2013;15. doi: 10.1007/s11910-016-0707-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-016-0707-9</ArticleId><ArticleId IdType="pubmed">27878525</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaves C.V., Rohrer J.D. An Update on Genetic Frontotemporal Dementia. J. Neurol. 2019;266:2075&#x2013;2086. doi: 10.1007/s00415-019-09363-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09363-4</ArticleId><ArticleId IdType="pmc">PMC6647117</ArticleId><ArticleId IdType="pubmed">31119452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., Zucchi E., Martinelli I., Van der Most L., Gianferrari G., Moglia C., Manera U., Solero L., Vasta R., Canosa A. Factors Predicting Disease Progression in C9ORF72 ALS Patients. J. Neurol. 2023;270:877&#x2013;890. doi: 10.1007/s00415-022-11426-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11426-y</ArticleId><ArticleId IdType="pubmed">36280624</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: From Genes to Mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.H., Li Y., Fukaya M., Lorenzini I., Cleveland D.W., Ostrow L.W., Rothstein J.D., Bergles D.E. Degeneration and Impaired Regeneration of Gray Matter Oligodendrocytes in Amyotrophic Lateral Sclerosis. Nat. Neurosci. 2013;16:571. doi: 10.1038/nn.3357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Velde C.V., Cleveland D.W. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L., Ferrari D., Andjus P.R., Buzanska L., Cantello R., De Marchi F., Gelati M., Giniatullin R., Glover J.C., Grilli M., et al. Advances in Stem Cell Therapy for Amyotrophic Lateral Sclerosis. Expert. Opin. Biol. Ther. 2018;18:865&#x2013;881. doi: 10.1080/14712598.2018.1503248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2018.1503248</ArticleId><ArticleId IdType="pubmed">30025485</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F., Franjkic T., Schito P., Russo T., Nimac J., Chami A.A., Mele A., Vidatic L., Kriz J., Julien J.-P. Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder. Biomedicines. 2023;11:1599. doi: 10.3390/biomedicines11061599.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11061599</ArticleId><ArticleId IdType="pmc">PMC10295684</ArticleId><ArticleId IdType="pubmed">37371694</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro R., Br&#xe1;s J., Hardy J. SnapShot: Genetics of ALS and FTD. Cell. 2015;160:798. doi: 10.1016/j.cell.2015.01.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.052</ArticleId><ArticleId IdType="pubmed">25679767</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.-X. Mutations in Cu/Zn Superoxide Dismutase Gene Are Associated with Familial Amyotrophic Lateral Sclerosis. Nature. 1993;362:59. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Bali T., Self W., Liu J., Siddique T., Wang L.H., Bird T.D., Ratti E., Atassi N., Boylan K.B., Glass J.D. Defining SOD1 ALS Natural History to Guide Therapeutic Clinical Trial Design. J. Neurol. Neurosurg. Psychiatry. 2017;88:99&#x2013;105. doi: 10.1136/jnnp-2016-313521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-313521</ArticleId><ArticleId IdType="pmc">PMC5136332</ArticleId><ArticleId IdType="pubmed">27261500</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassano M., Calvo A., Moglia C., Sbaiz L., Brunetti M., Barberis M., Casale F., Manera U., Vasta R., Canosa A. Systematic Evaluation of Genetic Mutations in ALS: A Population-Based Study. J. Neurol. Neurosurg. Psychiatry. 2022;93:1190&#x2013;1193. doi: 10.1136/jnnp-2022-328931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-328931</ArticleId><ArticleId IdType="pmc">PMC9606529</ArticleId><ArticleId IdType="pubmed">35896380</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N., Pozzi L., Russo T., Pipitone G.B., Schito P., Domi T., Agosta F., Quattrini A., Carrera P., Filippi M. NEK1 Variants in a Cohort of Italian Patients with Amyotrophic Lateral Sclerosis. Front. Neurosci. 2022;16:833051. doi: 10.3389/fnins.2022.833051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.833051</ArticleId><ArticleId IdType="pmc">PMC9048593</ArticleId><ArticleId IdType="pubmed">35495032</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel Genes Associated with Amyotrophic Lateral Sclerosis: Diagnostic and Clinical Implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Swieten J.C., Heutink P. Mutations in Progranulin (GRN) within the Spectrum of Clinical and Pathological Phenotypes of Frontotemporal Dementia. Lancet Neurol. 2008;7:965&#x2013;974. doi: 10.1016/S1474-4422(08)70194-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70194-7</ArticleId><ArticleId IdType="pubmed">18771956</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghetti B., Oblak A.L., Boeve B.F., Johnson K.A., Dickerson B.C., Goedert M. Invited Review: Frontotemporal Dementia Caused by Microtubule-associated Protein Tau Gene (MAPT) Mutations: A Chameleon for Neuropathology and Neuroimaging. Neuropathol. Appl. Neurobiol. 2015;41:24&#x2013;46. doi: 10.1111/nan.12213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12213</ArticleId><ArticleId IdType="pmc">PMC4329416</ArticleId><ArticleId IdType="pubmed">25556536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zeng P., Fang Y., Zhang T., Tian Q. Progranulin in Neurodegenerative Dementia. J. Neurochem. 2021;158:119&#x2013;137. doi: 10.1111/jnc.15378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15378</ArticleId><ArticleId IdType="pubmed">33930186</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon M.J., Logan T., DeVos S.L., Di Paolo G. Lysosomal Functions of Progranulin and Implications for Treatment of Frontotemporal Dementia. Trends Cell Biol. 2022;33:324&#x2013;339. doi: 10.1016/j.tcb.2022.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2022.09.006</ArticleId><ArticleId IdType="pubmed">36244875</ArticleId></ArticleIdList></Reference><Reference><Citation>Rademakers R., Cruts M., Van Broeckhoven C. The Role of Tau (MAPT) in Frontotemporal Dementia and Related Tauopathies. Hum. Mutat. 2004;24:277&#x2013;295. doi: 10.1002/humu.20086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20086</ArticleId><ArticleId IdType="pubmed">15365985</ArticleId></ArticleIdList></Reference><Reference><Citation>Strang K.H., Golde T.E., Giasson B.I. MAPT Mutations, Tauopathy, and Mechanisms of Neurodegeneration. Lab. Investig. 2019;99:912&#x2013;928. doi: 10.1038/s41374-019-0197-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41374-019-0197-x</ArticleId><ArticleId IdType="pmc">PMC7289372</ArticleId><ArticleId IdType="pubmed">30742061</ArticleId></ArticleIdList></Reference><Reference><Citation>Virgilio E., De Marchi F., Contaldi E., Dianzani U., Cantello R., Mazzini L., Comi C. The Role of Tau beyond Alzheimer&#x2019;s Disease: A Narrative Review. Biomedicines. 2022;10:760. doi: 10.3390/biomedicines10040760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040760</ArticleId><ArticleId IdType="pmc">PMC9026415</ArticleId><ArticleId IdType="pubmed">35453510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R., Kapogiannis D., D Huey E., Momeni P. FTD and ALS: A Tale of Two Diseases. Curr. Alzheimer Res. 2011;8:273&#x2013;294. doi: 10.2174/156720511795563700.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720511795563700</ArticleId><ArticleId IdType="pmc">PMC3801195</ArticleId><ArticleId IdType="pubmed">21222600</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-Mediated ALS and FTD: Multiple Pathways to Disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Velde C.V., Bouchard J.-P., Lacomblez L., Pochigaeva K., Salachas F. TARDBP Mutations in Individuals with Sporadic and Familial Amyotrophic Lateral Sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui R., Tuo M., Li P., Zhou C. Association between TBK1 Mutations and Risk of Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Spectrum: A Meta-Analysis. Neurol. Sci. 2018;39:811&#x2013;820. doi: 10.1007/s10072-018-3246-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3246-0</ArticleId><ArticleId IdType="pubmed">29349657</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Rouleau G.A., Kabashi E. TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update. Hum. Mutat. 2013;34:812&#x2013;826. doi: 10.1002/humu.22319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22319</ArticleId><ArticleId IdType="pubmed">23559573</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T. Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford N.J., Zhang Y.-J., Baker M., Gass J.M., Finch N.A., Xu Y.-F., Stewart H., Kelley B.J., Kuntz K., Crook R.J.P. Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis. PLoS Genet. 2008;4:e1000193. doi: 10.1371/journal.pgen.1000193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., Van Swieten J.C., Myllykangas L. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai S.C., Nana A.L., Yokoyama J.S., Seeley W.W. C9orf72-FTD/ALS Pathogenesis: Evidence from Human Neuropathological Studies. Acta Neuropathol. 2019;137:1&#x2013;26. doi: 10.1007/s00401-018-1921-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1921-0</ArticleId><ArticleId IdType="pmc">PMC6546170</ArticleId><ArticleId IdType="pubmed">30368547</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeyers J., Banchi E.-G., Latouche M. C9ORF72: What It Is, What It Does, and Why It Matters. Front. Cell Neurosci. 2021;15:661447. doi: 10.3389/fncel.2021.661447.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.661447</ArticleId><ArticleId IdType="pmc">PMC8131521</ArticleId><ArticleId IdType="pubmed">34025358</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M.A., Sundaramoorthy V., Sultana J.M., Yang S., Atkinson R.A.K., Levina V., Halloran M.A., Gleeson P.A., Blair I.P., Soo K.Y., et al. C9ORF72, Implicated in Amytrophic Lateral Sclerosis and Frontotemporal Dementia, Regulates Endosomal Trafficking. Hum. Mol. Genet. 2014;23:3579&#x2013;3595. doi: 10.1093/hmg/ddu068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu068</ArticleId><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Petrucelli L. Disease Mechanisms of C9ORF72 Repeat Expansions. Cold Spring Harb. Perspect. Med. 2018;8:a024224. doi: 10.1101/cshperspect.a024224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024224</ArticleId><ArticleId IdType="pmc">PMC5880161</ArticleId><ArticleId IdType="pubmed">28130314</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I., Camuzat A., Guerreiro R., Bouya-Ahmed K., Bras J., Nicolas G., Gabelle A., Didic M., De Septenville A., Millecamps S. SQSTM1 Mutations in French Patients with Frontotemporal Dementia or Frontotemporal Dementia with Amyotrophic Lateral Sclerosis. JAMA Neurol. 2013;70:1403&#x2013;1410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4199096</ArticleId><ArticleId IdType="pubmed">24042580</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., M&#xfc;ller K., Marroquin N., Nordin F., H&#xfc;bers A., Weydt P. Haploinsufficiency of TBK1 Causes Familial ALS and Fronto-Temporal Dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I., Van Mossevelde S., van der Zee J., Sieben A., Philtjens S., Heeman B., Engelborghs S., Vandenbulcke M., De Baets G., B&#xe4;umer V., et al. Loss of TBK1 Is a Frequent Cause of Frontotemporal Dementia in a Belgian Cohort. Neurology. 2015;85:2116&#x2013;2125. doi: 10.1212/WNL.0000000000002220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002220</ArticleId><ArticleId IdType="pmc">PMC4691687</ArticleId><ArticleId IdType="pubmed">26581300</ArticleId></ArticleIdList></Reference><Reference><Citation>Herhaus L. TBK1 (TANK-Binding Kinase 1)-Mediated Regulation of Autophagy in Health and Disease. Matrix Biol. 2021;100&#x2013;101:84&#x2013;98. doi: 10.1016/j.matbio.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2021.01.004</ArticleId><ArticleId IdType="pubmed">33454423</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M., van Blitterswijk M.M., Vlam L., Rowicka P.A., van Vught P.W.J., Groen E.J.N., Spliet W.G.M., Engelen-Lee J., Schelhaas H.J., de Visser M. VCP Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Neurobiol. Aging. 2012;33:837.e7&#x2013;837.e13. doi: 10.1016/j.neurobiolaging.2011.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.006</ArticleId><ArticleId IdType="pubmed">22078486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju J.-S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-Containing Protein (VCP) Is Required for Autophagy and Is Disrupted in VCP Disease. J. Cell Biol. 2009;187:875&#x2013;888. doi: 10.1083/jcb.200908115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908115</ArticleId><ArticleId IdType="pmc">PMC2806317</ArticleId><ArticleId IdType="pubmed">20008565</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H. Mutations of Optineurin in Amyotrophic Lateral Sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Bieniek K.F., Finch N., van de Vorst M., Baker M., Perkersen R., Brown P., Ravenscroft T., van Blitterswijk M., Nicholson A.M. Whole-Genome Sequencing Reveals Important Role for TBK1 and OPTN Mutations in Frontotemporal Lobar Degeneration without Motor Neuron Disease. Acta Neuropathol. 2015;130:77&#x2013;92. doi: 10.1007/s00401-015-1436-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1436-x</ArticleId><ArticleId IdType="pmc">PMC4470809</ArticleId><ArticleId IdType="pubmed">25943890</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W.-C., Li H.-Y., Chen G.-C., Chern Y., Tu P. Mutations in the Ubiquitin-Binding Domain of OPTN/Optineurin Interfere with Autophagy-Mediated Degradation of Misfolded Proteins by a Dominant-Negative Mechanism. Autophagy. 2015;11:685&#x2013;700. doi: 10.4161/auto.36098.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.36098</ArticleId><ArticleId IdType="pmc">PMC4502753</ArticleId><ArticleId IdType="pubmed">25484089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmer C., Schludi M.H., Ransom L., Greiling J., Jungh&#xe4;nel M., Exner N., Riemenschneider H., van der Zee J., Van Broeckhoven C., Weydt P., et al. A Novel CHCHD10 Mutation Implicates a Mia40-Dependent Mitochondrial Import Deficit in ALS. EMBO Mol. Med. 2018;10:e8558. doi: 10.15252/emmm.201708558.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708558</ArticleId><ArticleId IdType="pmc">PMC5991575</ArticleId><ArticleId IdType="pubmed">29789341</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronchi D., Riboldi G., Del Bo R., Ticozzi N., Scarlato M., Galimberti D., Corti S., Silani V., Bresolin N., Comi G. Pietro CHCHD10 Mutations in Italian Patients with Sporadic Amyotrophic Lateral Sclerosis. Brain. 2015;138:e372. doi: 10.1093/brain/awu384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu384</ArticleId><ArticleId IdType="pubmed">25576308</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaussenot A., Le Ber I., Ait-El-Mkadem S., Camuzat A., de Septenville A., Bannwarth S., Genin E.C., Serre V., Aug&#xe9; G., Brice A. Screening of CHCHD10 in a French Cohort Confirms the Involvement of This Gene in Frontotemporal Dementia with Amyotrophic Lateral Sclerosis Patients. Neurobiol. Aging. 2014;35:2884.e1&#x2013;2884.e4. doi: 10.1016/j.neurobiolaging.2014.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.022</ArticleId><ArticleId IdType="pubmed">25155093</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra A., Bandopadhyay R., Singh P.K., Mishra P.S., Sharma N., Khurana N. Neuroinflammation in Neurological Disorders: Pharmacotherapeutic Targets from Bench to Bedside. Metab. Brain Dis. 2021;36:1591&#x2013;1626. doi: 10.1007/s11011-021-00806-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-021-00806-4</ArticleId><ArticleId IdType="pubmed">34387831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon H.S., Koh S.-H. Neuroinflammation in Neurodegenerative Disorders: The Roles of Microglia and Astrocytes. Transl. Neurodegener. 2020;9:1&#x2013;12. doi: 10.1186/s40035-020-00221-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-020-00221-2</ArticleId><ArticleId IdType="pmc">PMC7689983</ArticleId><ArticleId IdType="pubmed">33239064</ArticleId></ArticleIdList></Reference><Reference><Citation>Comi C., Tondo G. Insights into the Protective Role of Immunity in Neurodegenerative Disease. Neural Regen. Res. 2017;12:64. doi: 10.4103/1673-5374.198980.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.198980</ArticleId><ArticleId IdType="pmc">PMC5319239</ArticleId><ArticleId IdType="pubmed">28250745</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson J., Nutma E., van der Valk P., Amor S. Inflammation in CNS Neurodegenerative Diseases. Immunology. 2018;154:204&#x2013;219. doi: 10.1111/imm.12922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12922</ArticleId><ArticleId IdType="pmc">PMC5980185</ArticleId><ArticleId IdType="pubmed">29513402</ArticleId></ArticleIdList></Reference><Reference><Citation>Peferoen L., Kipp M., van der Valk P., van Noort J.M., Amor S. Oligodendrocyte-microglia Cross-talk in the Central Nervous System. Immunology. 2014;141:302&#x2013;313. doi: 10.1111/imm.12163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12163</ArticleId><ArticleId IdType="pmc">PMC3930369</ArticleId><ArticleId IdType="pubmed">23981039</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Kummer M.P., Latz E. Innate Immune Activation in Neurodegenerative Disease. Nat. Rev. Immunol. 2014;14:463&#x2013;477. doi: 10.1038/nri3705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3705</ArticleId><ArticleId IdType="pubmed">24962261</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachiller S., Jim&#xe9;nez-Ferrer I., Paulus A., Yang Y., Swanberg M., Deierborg T., Boza-Serrano A. Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response. Front. Cell Neurosci. 2018;12:488. doi: 10.3389/fncel.2018.00488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00488</ArticleId><ArticleId IdType="pmc">PMC6305407</ArticleId><ArticleId IdType="pubmed">30618635</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman-Martinez L., Maccioni R.B., Andrade V., Navarrete L.P., Pastor M.G., Ramos-Escobar N. Neuroinflammation as a Common Feature of Neurodegenerative Disorders. Front. Pharmacol. 2019;10:1008. doi: 10.3389/fphar.2019.01008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01008</ArticleId><ArticleId IdType="pmc">PMC6751310</ArticleId><ArticleId IdType="pubmed">31572186</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., M&#xfc;nch A.E., Chung W.-S., Peterson T.C. Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Oksanen M., Lehtonen S., Jaronen M., Goldsteins G., H&#xe4;m&#xe4;l&#xe4;inen R.H., Koistinaho J. Astrocyte Alterations in Neurodegenerative Pathologies and Their Modeling in Human Induced Pluripotent Stem Cell Platforms. Cell. Mol. Life Sci. 2019;76:2739&#x2013;2760. doi: 10.1007/s00018-019-03111-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03111-7</ArticleId><ArticleId IdType="pmc">PMC6588647</ArticleId><ArticleId IdType="pubmed">31016348</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu J., Huang Y., Bao T., Liu C., Liu X., Chen X. The Role of Th17 Cells/IL-17A in AD, PD, ALS and the Strategic Therapy Targeting on IL-17A. J. Neuroinflammation. 2022;19:98. doi: 10.1186/s12974-022-02446-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02446-6</ArticleId><ArticleId IdType="pmc">PMC9034482</ArticleId><ArticleId IdType="pubmed">35459141</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer A., Winner B., Prots I. The Trojan Horse-Neuroinflammatory Impact of T Cells in Neurodegenerative Diseases. Mol. Neurodegener. 2017;12:1&#x2013;10. doi: 10.1186/s13024-017-0222-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0222-8</ArticleId><ArticleId IdType="pmc">PMC5658940</ArticleId><ArticleId IdType="pubmed">29078813</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T., Akiyama H., Yamada T., McGeer P.L. Immunologic Reactions in Amyotrophic Lateral Sclerosis Brain and Spinal Cord Tissue. Am. J. Pathol. 1992;140:691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt J.I., Tajti J., Appel S.H. Lymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral Sclerosis. Arch. Neurol. 1993;50:30&#x2013;36. doi: 10.1001/archneur.1993.00540010026013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1993.00540010026013</ArticleId><ArticleId IdType="pubmed">8093428</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Hewitt C., Highley J.R., Brockington A., Milano A., Man S., Martindale J., Hartley J., Walsh T., Gelsthorpe C. Clinico-Pathological Features in Amyotrophic Lateral Sclerosis with Expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory J.M., Livesey M.R., McDade K., Selvaraj B.T., Barton S.K., Chandran S., Smith C. Dysregulation of AMPA Receptor Subunit Expression in Sporadic ALS Post-mortem Brain. J. Pathol. 2020;250:67&#x2013;78. doi: 10.1002/path.5351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5351</ArticleId><ArticleId IdType="pmc">PMC6973025</ArticleId><ArticleId IdType="pubmed">31579943</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifai O.M., Longden J., O&#x2019;Shaughnessy J., Sewell M.D.E., Pate J., McDade K., Daniels M.J.D., Abrahams S., Chandran S., McColl B.W. Random Forest Modelling Demonstrates Microglial and Protein Misfolding Features to Be Key Phenotypic Markers in C9orf72-ALS. J. Pathol. 2022;258:366&#x2013;381. doi: 10.1002/path.6008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.6008</ArticleId><ArticleId IdType="pmc">PMC9827842</ArticleId><ArticleId IdType="pubmed">36070099</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinreich M., Shepheard S.R., Verber N., Wyles M., Heath P.R., Highley J.R., Kirby J., Shaw P.J. Neuropathological Characterization of a Novel TANK Binding Kinase (TBK1) Gene Loss of Function Mutation Associated with Amyotrophic Lateral Sclerosis. Neuropathol. Appl. Neurobiol. 2020;46:279&#x2013;291. doi: 10.1111/nan.12578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12578</ArticleId><ArticleId IdType="pubmed">31498468</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero E.N., Wang H., Mitra J., Hegde P.M., Stowell S.E., Liachko N.F., Kraemer B.C., Garruto R.M., Rao K.S., Hegde M.L. TDP-43/FUS in Motor Neuron Disease: Complexity and Challenges. Prog. Neurobiol. 2016;145:78&#x2013;97. doi: 10.1016/j.pneurobio.2016.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.09.004</ArticleId><ArticleId IdType="pmc">PMC5101148</ArticleId><ArticleId IdType="pubmed">27693252</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xe4;llstig E., McCabe B.D., Schneider B.L. The Links between ALS and NF-&#x39a;B. Int. J. Mol. Sci. 2021;22:3875. doi: 10.3390/ijms22083875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22083875</ArticleId><ArticleId IdType="pmc">PMC8070122</ArticleId><ArticleId IdType="pubmed">33918092</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x105;bek J., Ku&#x142;ach A., G&#x105;sior Z. Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-&#x39a;B): A New Potential Therapeutic Target in Atherosclerosis? Pharmacol. Rep. 2010;62:778&#x2013;783. doi: 10.1016/S1734-1140(10)70338-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1734-1140(10)70338-8</ArticleId><ArticleId IdType="pubmed">21098861</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A., McAvoy K., Krishnamurthy K., Trotti D., Pasinelli P. Astrocytes Expressing ALS-linked Mutant FUS Induce Motor Neuron Death through Release of Tumor Necrosis Factor-alpha. Glia. 2018;66:1016&#x2013;1033. doi: 10.1002/glia.23298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar-Kasza A., Hinteregger B., Neddens J., Rabl R., Flunkert S., Hutter-Paier B. Evaluation of Neuropathological Features in the SOD1-G93A Low Copy Number Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2021;14:681868. doi: 10.3389/fnmol.2021.681868.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.681868</ArticleId><ArticleId IdType="pmc">PMC8264456</ArticleId><ArticleId IdType="pubmed">34248499</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P. Microglia Induce Motor Neuron Death via the Classical NF-&#x39a;B Pathway in Amyotrophic Lateral Sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino M.M., Schneider C., Caroni P. Accumulation of SOD1 Mutants in Postnatal Motoneurons Does Not Cause Motoneuron Pathology or Motoneuron Disease. J. Neurosci. 2002;22:4825&#x2013;4832. doi: 10.1523/JNEUROSCI.22-12-04825.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-12-04825.2002</ArticleId><ArticleId IdType="pmc">PMC6757755</ArticleId><ArticleId IdType="pubmed">12077179</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F., Molawi K., Zychlinsky A. Mutant Superoxide Dismutase 1-Induced IL-1&#x3b2; Accelerates ALS Pathogenesis. Proc. Natl. Acad. Sci. USA. 2010;107:13046&#x2013;13050. doi: 10.1073/pnas.1002396107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002396107</ArticleId><ArticleId IdType="pmc">PMC2919927</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J. Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice. Science. 2003;302:113&#x2013;117. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo F., Komine O., Fujimori-Tonou N., Katsuno M., Jin S., Watanabe S., Sobue G., Dezawa M., Wyss-Coray T., Yamanaka K. Astrocyte-Derived TGF-&#x392;1 Accelerates Disease Progression in ALS Mice by Interfering with the Neuroprotective Functions of Microglia and T Cells. Cell Rep. 2015;11:592&#x2013;604. doi: 10.1016/j.celrep.2015.03.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.03.053</ArticleId><ArticleId IdType="pubmed">25892237</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Beers D.R., Wen S., Rivera A.L., Toennis K.M., Appel J.E., Zhao W., Moore D.H., Powell S.Z., Appel S.H. Regulatory T-lymphocytes Mediate Amyotrophic Lateral Sclerosis Progression and Survival. EMBO Mol. Med. 2013;5:64&#x2013;79. doi: 10.1002/emmm.201201544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201544</ArticleId><ArticleId IdType="pmc">PMC3569654</ArticleId><ArticleId IdType="pubmed">23143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I.M., Chen A., Zheng Y., Kosaras B., Tsiftsoglou S.A., Vartanian T.K., Brown R.H., Jr., Carroll M.C. T Lymphocytes Potentiate Endogenous Neuroprotective Inflammation in a Mouse Model of ALS. Proc. Natl. Acad. Sci. USA. 2008;105:17913&#x2013;17918. doi: 10.1073/pnas.0804610105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804610105</ArticleId><ArticleId IdType="pmc">PMC2581614</ArticleId><ArticleId IdType="pubmed">18997009</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberson E.D. Mouse Models of Frontotemporal Dementia. Ann. Neurol. 2012;72:837&#x2013;849. doi: 10.1002/ana.23722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23722</ArticleId><ArticleId IdType="pmc">PMC3539234</ArticleId><ArticleId IdType="pubmed">23280835</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin F., Banerjee R., Thomas B., Zhou P., Qian L., Jia T., Ma X., Ma Y., Iadecola C., Beal M.F. Exaggerated Inflammation, Impaired Host Defense, and Neuropathology in Progranulin-Deficient Mice. J. Exp. Med. 2010;207:117&#x2013;128. doi: 10.1084/jem.20091568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20091568</ArticleId><ArticleId IdType="pmc">PMC2812536</ArticleId><ArticleId IdType="pubmed">20026663</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 Mutant Transgenic Mice Develop Features of ALS and Frontotemporal Lobar Degeneration. Proc. Natl. Acad. Sci. USA. 2009;106:18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Pattamatta A., Zu T., Reid T., Bardhi O., Borchelt D.R., Yachnis A.T., Ranum L.P.W. C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD. Neuron. 2016;90:521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridler C. Loss of TDP-43 in Microglia&#x2014;Friend or Foe? Nat. Rev. Neurol. 2017;13:449. doi: 10.1038/nrneurol.2017.103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.103</ArticleId><ArticleId IdType="pubmed">28708134</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R.C., Jawaid A., Henstridge C.M., Valeri A., Merlini M., Robinson J.L., Lee E.B., Rose J., Appel S., Lee V.M.-Y. TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss. Neuron. 2017;95:297&#x2013;308. doi: 10.1016/j.neuron.2017.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.05.037</ArticleId><ArticleId IdType="pmc">PMC5519492</ArticleId><ArticleId IdType="pubmed">28669544</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D., Lorenzini I., Mota T.A., Bell S., Mahan T.E., Ulrich J.D., Davtyan H., Rexach J.E., Muhammad A.K.M.G., Shelest O. C9orf72 Deficiency Promotes Microglial-Mediated Synaptic Loss in Aging and Amyloid Accumulation. Neuron. 2021;109:2275&#x2013;2291. doi: 10.1016/j.neuron.2021.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.05.020</ArticleId><ArticleId IdType="pmc">PMC8298293</ArticleId><ArticleId IdType="pubmed">34133945</ArticleId></ArticleIdList></Reference><Reference><Citation>Swift I.J., Sogorb-Esteve A., Heller C., Synofzik M., Otto M., Graff C., Galimberti D., Todd E., Heslegrave A.J., van der Ende E.L. Fluid Biomarkers in Frontotemporal Dementia: Past, Present and Future. J. Neurol. Neurosurg. Psychiatry. 2021;92:204&#x2013;215. doi: 10.1136/jnnp-2020-323520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323520</ArticleId><ArticleId IdType="pubmed">33188134</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O., Lehmann S., Otto M., Zetterberg H., Lewczuk P. Advantages and Disadvantages of the Use of the CSF Amyloid &#x3b2; (A&#x3b2;) 42/40 Ratio in the Diagnosis of Alzheimer&#x2019;s Disease. Alzheimers Res. Ther. 2019;11:1&#x2013;15. doi: 10.1186/s13195-019-0485-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0485-0</ArticleId><ArticleId IdType="pmc">PMC6477717</ArticleId><ArticleId IdType="pubmed">31010420</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouclet-Courtemanche H., Nguyen T.-B., Skrobala E., Boutoleau-Bretonni&#xe8;re C., Pasquier F., Bouaziz-Amar E., Bigot-Corbel E., Schraen S., Dumurgier J., Paquet C. Frontotemporal Dementia Is the Leading Cause of &#x201c;True&#x201d; A&#x2212;/T+ Profiles Defined with A&#x3b2;42/40 Ratio. Alzheimer&#x2019;s Dement. Diagn. Assess. Dis. Monit. 2019;11:161&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6378630</ArticleId><ArticleId IdType="pubmed">30815533</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu P.-Y., Yang F.-C., Chiu M.-J., Lin W.-C., Lu C.-H., Yang S.-Y. Relevance of Plasma Biomarkers to Pathologies in Alzheimer&#x2019;s Disease, Parkinson&#x2019;s Disease and Frontotemporal Dementia. Sci. Rep. 2022;12:17919. doi: 10.1038/s41598-022-22647-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-22647-6</ArticleId><ArticleId IdType="pmc">PMC9605966</ArticleId><ArticleId IdType="pubmed">36289355</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzeff J.S., Bright F., Phan K., Kril J.J., Ittner L.M., Kassiou M., Hodges J.R., Piguet O., Kiernan M.C., Halliday G.M. Biomarker Discovery and Development for Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Brain. 2022;145:1598&#x2013;1609. doi: 10.1093/brain/awac077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac077</ArticleId><ArticleId IdType="pmc">PMC9166557</ArticleId><ArticleId IdType="pubmed">35202463</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaetani L., Blennow K., Calabresi P., Di Filippo M., Parnetti L., Zetterberg H. Neurofilament Light Chain as a Biomarker in Neurological Disorders. J. Neurol. Neurosurg. Psychiatry. 2019;90:870&#x2013;881. doi: 10.1136/jnnp-2018-320106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-320106</ArticleId><ArticleId IdType="pubmed">30967444</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridel C., Van Wieringen W.N., Zetterberg H., Tijms B.M., Teunissen C.E., Alvarez-Cerme&#xf1;o J.C., Andreasson U., Axelsson M., B&#xe4;ckstr&#xf6;m D.C., Bartos A. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-Analysis. JAMA Neurol. 2019;76:1035&#x2013;1048. doi: 10.1001/jamaneurol.2019.1534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.1534</ArticleId><ArticleId IdType="pmc">PMC6580449</ArticleId><ArticleId IdType="pubmed">31206160</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F., Steinacker P., Weishaupt J.H., Kassubek J., Oeckl P., Halbgebauer S., Tumani H., von Arnim C.A.F., Dorst J., Feneberg E. Neurofilament Light Chain in Serum for the Diagnosis of Amyotrophic Lateral Sclerosis. J. Neurol. Neurosurg. Psychiatry. 2019;90:157&#x2013;164. doi: 10.1136/jnnp-2018-318704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318704</ArticleId><ArticleId IdType="pubmed">30309882</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Qin X., Chang X., Wang H., Guo J., Zhang W. Neurofilament Markers in Serum and Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis. J. Cell Mol. Med. 2022;26:583&#x2013;587. doi: 10.1111/jcmm.17100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.17100</ArticleId><ArticleId IdType="pmc">PMC8743649</ArticleId><ArticleId IdType="pubmed">34866307</ArticleId></ArticleIdList></Reference><Reference><Citation>Landqvist Wald&#xf6; M., Frizell Santillo A., Passant U., Zetterberg H., Rosengren L., Nilsson C., Englund E. Cerebrospinal Fluid Neurofilament Light Chain Protein Levels in Subtypes of Frontotemporal Dementia. BMC Neurol. 2013;13:1&#x2013;8. doi: 10.1186/1471-2377-13-54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-13-54</ArticleId><ArticleId IdType="pmc">PMC3671150</ArticleId><ArticleId IdType="pubmed">23718879</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi S., Patel S.K., Eratne D., Kyndt C., Reidy N., Lewis C., Lee S., Darby D., Brodtmann A. Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes. J. Alzheimer&#x2019;s Dis. 2022:1&#x2013;11. doi: 10.3233/JAD-220272. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220272</ArticleId><ArticleId IdType="pmc">PMC9661326</ArticleId><ArticleId IdType="pubmed">35988220</ArticleId></ArticleIdList></Reference><Reference><Citation>Spotorno N., Lindberg O., Nilsson C., Landqvist Wald&#xf6; M., Van Westen D., Nilsson K., Vestberg S., Englund E., Zetterberg H., Blennow K. Plasma Neurofilament Light Protein Correlates with Diffusion Tensor Imaging Metrics in Frontotemporal Dementia. PLoS ONE. 2020;15:e0236384. doi: 10.1371/journal.pone.0236384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236384</ArticleId><ArticleId IdType="pmc">PMC7591030</ArticleId><ArticleId IdType="pubmed">33108404</ArticleId></ArticleIdList></Reference><Reference><Citation>Saracino D., Dorgham K., Camuzat A., Rinaldi D., Rametti-Lacroux A., Houot M., Clot F., Martin-Hardy P., Jornea L., Azuar C. Plasma NfL Levels and Longitudinal Change Rates in C9orf72 and GRN-Associated Diseases: From Tailored References to Clinical Applications. J. Neurol. Neurosurg. Psychiatry. 2021;92:1278&#x2013;1288. doi: 10.1136/jnnp-2021-326914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-326914</ArticleId><ArticleId IdType="pmc">PMC8606463</ArticleId><ArticleId IdType="pubmed">34349004</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeter L.H., Dopper E.G., Jiskoot L.C., Sanchez-Valle R., Graff C., Benussi L., Ghidoni R., Pijnenburg Y.A., Borroni B., Galimberti D. Neurofilament Light Chain: A Biomarker for Genetic Frontotemporal Dementia. Ann. Clin. Transl. Neurol. 2016;3:623&#x2013;636. doi: 10.1002/acn3.325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.325</ArticleId><ArticleId IdType="pmc">PMC4999594</ArticleId><ArticleId IdType="pubmed">27606344</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang F., Zhu Y., Hsiao-Nakamoto J., Tang X., Dugas J.C., Moscovitch-Lopatin M., Glass J.D., Brown R.H., Jr., Ladha S.S., Lacomis D. Longitudinal Biomarkers in Amyotrophic Lateral Sclerosis. Ann. Clin. Transl. Neurol. 2020;7:1103&#x2013;1116. doi: 10.1002/acn3.51078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51078</ArticleId><ArticleId IdType="pmc">PMC7359115</ArticleId><ArticleId IdType="pubmed">32515902</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;land L.-C., Markovinovic A., Jakovac H., de Marchi F., Bilic E., Mazzini L., Kriz J., Munitic I. Immunity in Amyotrophic Lateral Sclerosis: Blurred Lines between Excessive Inflammation and Inefficient Immune Responses. Brain Commun. 2020;2:fcaa124. doi: 10.1093/braincomms/fcaa124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa124</ArticleId><ArticleId IdType="pmc">PMC7585698</ArticleId><ArticleId IdType="pubmed">33134918</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F., Munitic I., Amedei A., Berry J.D., Feldman E.L., Aronica E., Nardo G., Van Weehaeghe D., Niccolai E., Prtenjaca N. Interplay between Immunity and Amyotrophic Lateral Sclerosis: Clinical Impact. Neurosci. Biobehav. Rev. 2021;127:958&#x2013;978. doi: 10.1016/j.neubiorev.2021.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2021.06.027</ArticleId><ArticleId IdType="pmc">PMC8428677</ArticleId><ArticleId IdType="pubmed">34153344</ArticleId></ArticleIdList></Reference><Reference><Citation>Renkema G.H., Boot R.G., Au F.L., Donker-Koopman W.E., Strijland A., Muijsers A.O., Hrebicek M., Aerts J.M.F.G. Chitotriosidase, a Chitinase, and the 39-kDa Human Cartilage Glycoprotein, a Chitin-binding Lectin, Are Homologues of Family 18 Glycosyl Hydrolases Secreted by Human Macrophages. Eur. J. Biochem. 1998;251:504&#x2013;509. doi: 10.1046/j.1432-1327.1998.2510504.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1327.1998.2510504.x</ArticleId><ArticleId IdType="pubmed">9492324</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyanagi M., Egashira K., Kitamoto S., Ni W., Shimokawa H., Takeya M., Yoshimura T., Takeshita A. Role of Monocyte Chemoattractant Protein-1 in Cardiovascular Remodeling Induced by Chronic Blockade of Nitric Oxide Synthesis. Circulation. 2000;102:2243&#x2013;2248. doi: 10.1161/01.CIR.102.18.2243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.102.18.2243</ArticleId><ArticleId IdType="pubmed">11056100</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckl P., Weydt P., Steinacker P., Anderl-Straub S., Nordin F., Volk A.E., Diehl-Schmid J., Andersen P.M., Kornhuber J., Danek A. Different Neuroinflammatory Profile in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Is Linked to the Clinical Phase. J. Neurol. Neurosurg. Psychiatry. 2019;90:4&#x2013;10. doi: 10.1136/jnnp-2018-318868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318868</ArticleId><ArticleId IdType="pubmed">30224549</ArticleId></ArticleIdList></Reference><Reference><Citation>Barschke P., Oeckl P., Steinacker P., Al Shweiki M.H.D.R., Weishaupt J.H., Landwehrmeyer G.B., Anderl-Straub S., Weydt P., Diehl-Schmid J., Danek A. Different CSF Protein Profiles in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia with C9orf72 Hexanucleotide Repeat Expansion. J. Neurol. Neurosurg. Psychiatry. 2020;91:503&#x2013;511. doi: 10.1136/jnnp-2019-322476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322476</ArticleId><ArticleId IdType="pubmed">32132225</ArticleId></ArticleIdList></Reference><Reference><Citation>Heller C., Foiani M.S., Moore K., Convery R., Bocchetta M., Neason M., Cash D.M., Thomas D., Greaves C.V., Woollacott I.O., et al. Plasma Glial Fibrillary Acidic Protein Is Raised in Progranulin-Associated Frontotemporal Dementia. J. Neurol. Neurosurg. Psychiatry. 2020;91:263&#x2013;270. doi: 10.1136/jnnp-2019-321954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321954</ArticleId><ArticleId IdType="pubmed">31937580</ArticleId></ArticleIdList></Reference><Reference><Citation>Galimberti D., Bonsi R., Fenoglio C., Serpente M., Cioffi S.M.G., Fumagalli G., Arighi A., Ghezzi L., Arcaro M., Mercurio M., et al. Inflammatory Molecules in Frontotemporal Dementia: Cerebrospinal Fluid Signature of Progranulin Mutation Carriers. Brain Behav. Immun. 2015;49:182&#x2013;187. doi: 10.1016/j.bbi.2015.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.05.006</ArticleId><ArticleId IdType="pubmed">26021560</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazaheri F., Snaidero N., Kleinberger G., Madore C., Daria A., Werner G., Krasemann S., Capell A., Tr&#xfc;mbach D., Wurst W. TREM 2 Deficiency Impairs Chemotaxis and Microglial Responses to Neuronal Injury. EMBO Rep. 2017;18:1186&#x2013;1198. doi: 10.15252/embr.201743922.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201743922</ArticleId><ArticleId IdType="pmc">PMC5494532</ArticleId><ArticleId IdType="pubmed">28483841</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;hrfelt A., Axelsson M., Malmestr&#xf6;m C., Novakova L., Heslegrave A., Blennow K., Lycke J., Zetterberg H. Soluble TREM-2 in Cerebrospinal Fluid from Patients with Multiple Sclerosis Treated with Natalizumab or Mitoxantrone. Mult. Scler. J. 2016;22:1587&#x2013;1595. doi: 10.1177/1352458515624558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458515624558</ArticleId><ArticleId IdType="pubmed">26754805</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona S., Zahs K., Wu E., Dakin K., Bras J., Guerreiro R. The Role of TREM2 in Alzheimer&#x2019;s Disease and Other Neurodegenerative Disorders. Lancet Neurol. 2018;17:721&#x2013;730. doi: 10.1016/S1474-4422(18)30232-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30232-1</ArticleId><ArticleId IdType="pubmed">30033062</ArticleId></ArticleIdList></Reference><Reference><Citation>Morenas-Rodr&#xed;guez E., Li Y., Nuscher B., Franzmeier N., Xiong C., Su&#xe1;rez-Calvet M., Fagan A.M., Schultz S., Gordon B.A., Benzinger T.L.S. Soluble TREM2 in CSF and Its Association with Other Biomarkers and Cognition in Autosomal-Dominant Alzheimer&#x2019;s Disease: A Longitudinal Observational Study. Lancet Neurol. 2022;21:329&#x2013;341. doi: 10.1016/S1474-4422(22)00027-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00027-8</ArticleId><ArticleId IdType="pmc">PMC8926925</ArticleId><ArticleId IdType="pubmed">35305339</ArticleId></ArticleIdList></Reference><Reference><Citation>Paloneva J., Kestil&#xe4; M., Wu J., Salminen A., B&#xf6;hling T., Ruotsalainen V., Hakola P., Bakker A.B.H., Phillips J.H., Pekkarinen P. Loss-of-Function Mutations in TYROBP (DAP12) Result in a Presenile Dementia with Bone Cysts. Nat. Genet. 2000;25:357&#x2013;361. doi: 10.1038/77153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/77153</ArticleId><ArticleId IdType="pubmed">10888890</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I., De Septenville A., Guerreiro R., Bras J., Camuzat A., Caroppo P., Lattante S., Couarch P., Kabashi E., Bouya-Ahmed K. Homozygous TREM2 Mutation in a Family with Atypical Frontotemporal Dementia. Neurobiol. Aging. 2014;35:2419.e23&#x2013;2419.e25. doi: 10.1016/j.neurobiolaging.2014.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.04.010</ArticleId><ArticleId IdType="pmc">PMC4208293</ArticleId><ArticleId IdType="pubmed">24910390</ArticleId></ArticleIdList></Reference><Reference><Citation>Woollacott I.O.C., Nicholas J.M., Heslegrave A., Heller C., Foiani M.S., Dick K.M., Russell L.L., Paterson R.W., Keshavan A., Fox N.C. Cerebrospinal Fluid Soluble TREM2 Levels in Frontotemporal Dementia Differ by Genetic and Pathological Subgroup. Alzheimers Res. Ther. 2018;10:1&#x2013;14. doi: 10.1186/s13195-018-0405-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-018-0405-8</ArticleId><ArticleId IdType="pmc">PMC6094471</ArticleId><ArticleId IdType="pubmed">30111356</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghidoni R., Stoppani E., Rossi G., Piccoli E., Albertini V., Paterlini A., Glionna M., Pegoiani E., Agnati L.F., Fenoglio C. Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian Study. Neurodegener. Dis. 2012;9:121&#x2013;127. doi: 10.1159/000333132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000333132</ArticleId><ArticleId IdType="pubmed">22123177</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellami L., Rucheton B., Ben Younes I., Camuzat A., Saracino D., Rinaldi D., Epelbaum S., Azuar C., Levy R., Auriacombe S. Plasma Progranulin Levels for Frontotemporal Dementia in Clinical Practice: A 10-Year French Experience. Neurobiol. Aging. 2020;91:167.e1&#x2013;167.e9. doi: 10.1016/j.neurobiolaging.2020.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.02.014</ArticleId><ArticleId IdType="pubmed">32171590</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P., Hendrich C., Sperfeld A.D., Jesse S., von Arnim C.A.F., Lehnert S., Pabst A., Uttner I., Tumani H., Lee V.M.-Y., et al. TDP-43 in Cerebrospinal Fluid of Patients with Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Arch. Neurol. 2008;65:1481&#x2013;1487. doi: 10.1001/archneur.65.11.1481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.11.1481</ArticleId><ArticleId IdType="pmc">PMC2690860</ArticleId><ArticleId IdType="pubmed">19001167</ArticleId></ArticleIdList></Reference><Reference><Citation>Foulds P., McAuley E., Gibbons L., Davidson Y., Pickering-Brown S.M., Neary D., Snowden J.S., Allsop D., Mann D.M.A. TDP-43 Protein in Plasma May Index TDP-43 Brain Pathology in Alzheimer&#x2019;s Disease and Frontotemporal Lobar Degeneration. Acta Neuropathol. 2008;116:141&#x2013;146. doi: 10.1007/s00401-008-0389-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0389-8</ArticleId><ArticleId IdType="pmc">PMC2464623</ArticleId><ArticleId IdType="pubmed">18506455</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini M.L., Hillis A.E., Weintraub S., Kertesz A., Mendez M., Cappa S.F., Ogar J.M., Rohrer J.D., Black S., Boeve B.F., et al. Classification of Primary Progressive Aphasia and Its Variants. Neurology. 2011;76:1006&#x2013;1014. doi: 10.1212/WNL.0b013e31821103e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821103e6</ArticleId><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai R.M., Bejanin A., Lesman-Segev O., LaJoie R., Visani A., Bourakova V., O&#x2019;Neil J.P., Janabi M., Baker S., Lee S.E. 18 F-Flortaucipir (AV-1451) Tau PET in Frontotemporal Dementia Syndromes. Alzheimers Res. Ther. 2019;11:1&#x2013;18. doi: 10.1186/s13195-019-0470-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0470-7</ArticleId><ArticleId IdType="pmc">PMC6357510</ArticleId><ArticleId IdType="pubmed">30704514</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C.-H., Chen T.-F., Chiu M.-J., Yen R.-F., Shih M.-C., Lin C.-H. Integrated 18F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders. Front. Aging Neurosci. 2021;13:646440. doi: 10.3389/fnagi.2021.646440.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.646440</ArticleId><ArticleId IdType="pmc">PMC8039308</ArticleId><ArticleId IdType="pubmed">33854426</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Altomare D., Festari C., Orini S., Gandolfo F., Boccardi M., Arbizu J., Bouwman F., Drzezga A., Nestor P. Clinical Utility of FDG-PET in Amyotrophic Lateral Sclerosis and Huntington&#x2019;s Disease. Eur. J. Nucl. Med. Mol. Imaging. 2018;45:1546&#x2013;1556. doi: 10.1007/s00259-018-4033-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-018-4033-0</ArticleId><ArticleId IdType="pubmed">29717332</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan V., Pioro E.P. Comparing Brain Structural MRI and Metabolic FDG-PET Changes in Patients with ALS-FTD:&#x2018;The Chicken or the Egg?&#x2019;Question. J. Neurol. Neurosurg. Psychiatry. 2015;86:952&#x2013;958. doi: 10.1136/jnnp-2014-308239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-308239</ArticleId><ArticleId IdType="pubmed">25520437</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F., Stecco A., Falaschi Z., Filippone F., Pasch&#xe9; A., Bebeti A., Leigheb M., Cantello R., Mazzini L. Detection of White Matter Ultrastructural Changes for Amyotrophic Lateral Sclerosis Characterization: A Diagnostic Study from Dti-Derived Data. Brain Sci. 2020;10:996. doi: 10.3390/brainsci10120996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10120996</ArticleId><ArticleId IdType="pmc">PMC7766961</ArticleId><ArticleId IdType="pubmed">33339434</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A., Pagani M., Cistaro A., Montuschi A., Iazzolino B., Fania P., Cammarosano S., Ilardi A., Moglia C., Calvo A., et al. 18 F-FDG-PET Correlates of Cognitive Impairment in ALS. Neurology. 2016;86:44&#x2013;49. doi: 10.1212/WNL.0000000000002242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002242</ArticleId><ArticleId IdType="pubmed">26590270</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadar M., Manera A.L., Zinman L., Korngut L., Genge A., Graham S.J., Frayne R., Collins D.L., Kalra S. Cerebral Atrophy in Amyotrophic Lateral Sclerosis Parallels the Pathological Distribution of TDP43. Brain Commun. 2020;2:fcaa061. doi: 10.1093/braincomms/fcaa061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa061</ArticleId><ArticleId IdType="pmc">PMC7846188</ArticleId><ArticleId IdType="pubmed">33543125</ArticleId></ArticleIdList></Reference><Reference><Citation>Tondo G., Mazzini L., Caminiti S.P., Sarnelli M.F., Corrado L., Matheoud R., D&#x2019;Alfonso S., Cantello R., Sacchetti G.M., Perani D. Clinical Relevance of Single-Subject Brain Metabolism Patterns in Amyotrophic Lateral Sclerosis Mutation Carriers. Neuroimage Clin. 2022;36:103222. doi: 10.1016/j.nicl.2022.103222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.103222</ArticleId><ArticleId IdType="pmc">PMC9668615</ArticleId><ArticleId IdType="pubmed">36223668</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vocht J., Van Weehaeghe D., Ombelet F., Masrori P., Lamaire N., Devrome M., Van Esch H., Moisse M., Koole M., Dupont P. Differences in Cerebral Glucose Metabolism in ALS Patients with and without C9orf72 and SOD1 Mutations. Cells. 2023;12:933. doi: 10.3390/cells12060933.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12060933</ArticleId><ArticleId IdType="pmc">PMC10047407</ArticleId><ArticleId IdType="pubmed">36980274</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli E.G., Ghirelli A., Basaia S., Cividini C., Riva N., Canu E., Castelnovo V., Domi T., Magnani G., Caso F. Structural MRI Signatures in Genetic Presentations of the Frontotemporal Dementia/Motor Neuron Disease Spectrum. Neurology. 2021;97:e1594&#x2013;e1607. doi: 10.1212/WNL.0000000000012702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012702</ArticleId><ArticleId IdType="pmc">PMC8548958</ArticleId><ArticleId IdType="pubmed">34544819</ArticleId></ArticleIdList></Reference><Reference><Citation>Tondo G., Boccalini C., Caminiti S.P., Presotto L., Filippi M., Magnani G., Frisoni G.B., Iannaccone S., Perani D. Brain Metabolism and Microglia Activation in Mild Cognitive Impairment: A Combined [18F] FDG and [11C]-(R)-PK11195 PET Study. J. Alzheimer&#x2019;s Dis. 2021;80:433&#x2013;445. doi: 10.3233/JAD-201351.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-201351</ArticleId><ArticleId IdType="pubmed">33579848</ArticleId></ArticleIdList></Reference><Reference><Citation>Passamonti L., Rodr&#xed;guez P.V., Hong Y.T., Allinson K.S.J., Bevan-Jones W.R., Williamson D., Jones P.S., Arnold R., Borchert R.J., Surendranathan A. [11C] PK11195 Binding in Alzheimer Disease and Progressive Supranuclear Palsy. Neurology. 2018;90:e1989&#x2013;e1996. doi: 10.1212/WNL.0000000000005610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005610</ArticleId><ArticleId IdType="pmc">PMC5980519</ArticleId><ArticleId IdType="pubmed">29703774</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;bler D., W&#xe4;chter T., Cabanel N., Su Z., Turkheimer F.E., Dodel R., Brooks D.J., Oertel W.H., Gerhard A. Widespread Microglial Activation in Multiple System Atrophy. Mov. Disord. 2019;34:564&#x2013;568. doi: 10.1002/mds.27620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27620</ArticleId><ArticleId IdType="pmc">PMC6659386</ArticleId><ArticleId IdType="pubmed">30726574</ArticleId></ArticleIdList></Reference><Reference><Citation>Schain M., Kreisl W.C. Neuroinflammation in Neurodegenerative Disorders&#x2014;A Review. Curr. Neurol. Neurosci. Rep. 2017;17:1&#x2013;11. doi: 10.1007/s11910-017-0733-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-017-0733-2</ArticleId><ArticleId IdType="pubmed">28283959</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagnin A., Rossor M., Sampson E.L., MacKinnon T., Banati R.B. In Vivo Detection of Microglial Activation in Frontotemporal Dementia. Ann. Neurol. Off. J. Am. Neurol. Assoc. Child. Neurol. Soc. 2004;56:894&#x2013;897. doi: 10.1002/ana.20332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20332</ArticleId><ArticleId IdType="pubmed">15562429</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J. Mapping Neuroinflammation in Frontotemporal Dementia with Molecular PET Imaging. J. Neuroinflammation. 2015;12:1&#x2013;7. doi: 10.1186/s12974-015-0236-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0236-5</ArticleId><ArticleId IdType="pmc">PMC4451729</ArticleId><ArticleId IdType="pubmed">26022249</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyoshi M., Shinotoh H., Wszolek Z.K., Strongosky A.J., Shimada H., Arakawa R., Higuchi M., Ikoma Y., Yasuno F., Fukushi K. In Vivo Detection of Neuropathologic Changes in Presymptomatic MAPT Mutation Carriers: A PET and MRI Study. Park. Relat. Disord. 2010;16:404&#x2013;408. doi: 10.1016/j.parkreldis.2010.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2010.04.004</ArticleId><ArticleId IdType="pubmed">20452812</ArticleId></ArticleIdList></Reference><Reference><Citation>Lant S.B., Robinson A.C., Thompson J.C., Rollinson S., Pickering-Brown S., Snowden J.S., Davidson Y.S., Gerhard A., Mann D.M.A. Patterns of Microglial Cell Activation in Frontotemporal Lobar Degeneration. Neuropathol. Appl. Neurobiol. 2014;40:686&#x2013;696. doi: 10.1111/nan.12092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12092</ArticleId><ArticleId IdType="pubmed">24117616</ArticleId></ArticleIdList></Reference><Reference><Citation>Malpetti M., Rittman T., Jones P.S., Cope T.E., Passamonti L., Bevan-Jones W.R., Patterson K., Fryer T.D., Hong Y.T., Aigbirhio F.I. In Vivo PET Imaging of Neuroinflammation in Familial Frontotemporal Dementia. J. Neurol. Neurosurg. Psychiatry. 2021;92:319&#x2013;322. doi: 10.1136/jnnp-2020-323698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323698</ArticleId><ArticleId IdType="pmc">PMC7892378</ArticleId><ArticleId IdType="pubmed">33122395</ArticleId></ArticleIdList></Reference><Reference><Citation>Malpetti M., Cope T.E., Street D., Jones P.S., Hezemans F.H., Mak E., Tsvetanov K.A., Rittman T., Bevan-Jones W.R., Patterson K. Microglial Activation in the Frontal Cortex Predicts Cognitive Decline in Frontotemporal Dementia. Brain. 2023;146:3221&#x2013;3231. doi: 10.1093/brain/awad078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awad078</ArticleId><ArticleId IdType="pmc">PMC10393407</ArticleId><ArticleId IdType="pubmed">36883644</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C.J., Shaw C.E., Brooks D.J., Leigh P.N., Banati R.B. Evidence of Widespread Cerebral Microglial Activation in Amyotrophic Lateral Sclerosis: An [11C](R)-PK11195 Positron Emission Tomography Study. Neurobiol. Dis. 2004;15:601&#x2013;609. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshikho M.J., Z&#xfc;rcher N.R., Loggia M.L., Cernasov P., Reynolds B., Pijanowski O., Chonde D.B., Izquierdo Garcia D., Mainero C., Catana C. Integrated Magnetic Resonance Imaging and [11C]-PBR28 Positron Emission Tomographic Imaging in Amyotrophic Lateral Sclerosis. Ann. Neurol. 2018;83:1186&#x2013;1197. doi: 10.1002/ana.25251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25251</ArticleId><ArticleId IdType="pmc">PMC6105567</ArticleId><ArticleId IdType="pubmed">29740862</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Tauber C., Vercoullie J., Arlicot N., Prunier C., Praline J., Nicolas G., Venel Y., Hommet C., Baulieu J.-L. Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis. PLoS ONE. 2012;7:e52941. doi: 10.1371/journal.pone.0052941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052941</ArticleId><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshikho M.J., Z&#xfc;rcher N.R., Loggia M.L., Cernasov P., Chonde D.B., Garcia D.I., Yasek J.E., Akeju O., Catana C., Rosen B.R. Glial Activation Colocalizes with Structural Abnormalities in Amyotrophic Lateral Sclerosis. Neurology. 2016;87:2554&#x2013;2561. doi: 10.1212/WNL.0000000000003427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003427</ArticleId><ArticleId IdType="pmc">PMC5207001</ArticleId><ArticleId IdType="pubmed">27837005</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;rcher N.R., Loggia M.L., Lawson R., Chonde D.B., Izquierdo-Garcia D., Yasek J.E., Akeju O., Catana C., Rosen B.R., Cudkowicz M.E. Increased in Vivo Glial Activation in Patients with Amyotrophic Lateral Sclerosis: Assessed with [11C]-PBR28. Neuroimage Clin. 2015;7:409&#x2013;414. doi: 10.1016/j.nicl.2015.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2015.01.009</ArticleId><ArticleId IdType="pmc">PMC4310932</ArticleId><ArticleId IdType="pubmed">25685708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratai E.-M., Alshikho M.J., Z&#xfc;rcher N.R., Loggia M.L., Cebulla C.L., Cernasov P., Reynolds B., Fish J., Seth R., Babu S. Integrated Imaging of [11C]-PBR28 PET, MR Diffusion and Magnetic Resonance Spectroscopy 1H-MRS in Amyotrophic Lateral Sclerosis. Neuroimage Clin. 2018;20:357&#x2013;364. doi: 10.1016/j.nicl.2018.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.08.007</ArticleId><ArticleId IdType="pmc">PMC6092554</ArticleId><ArticleId IdType="pubmed">30112276</ArticleId></ArticleIdList></Reference><Reference><Citation>Tondo G., Iaccarino L., Cerami C., Vanoli G.E., Presotto L., Masiello V., Coliva A., Salvi F., Bartolomei I., Mosca L. 11C-PK11195 PET&#x2013;Based Molecular Study of Microglia Activation in SOD1 Amyotrophic Lateral Sclerosis. Ann. Clin. Transl. Neurol. 2020;7:1513&#x2013;1523. doi: 10.1002/acn3.51112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51112</ArticleId><ArticleId IdType="pmc">PMC7480909</ArticleId><ArticleId IdType="pubmed">32762033</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Goldacre R., Ramagopalan S., Talbot K., Goldacre M.J. Autoimmune Disease Preceding Amyotrophic Lateral Sclerosis: An Epidemiologic Study. Neurology. 2013;81:1222&#x2013;1225. doi: 10.1212/WNL.0b013e3182a6cc13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a6cc13</ArticleId><ArticleId IdType="pmc">PMC3795611</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin T., Huang W., Cao F., Yu X., Guo S., Ying Z., Xu C. Causal Association between Systemic Lupus Erythematosus and the Risk of Dementia: A Mendelian Randomization Study. Front. Immunol. 2022;13:1063110. doi: 10.3389/fimmu.2022.1063110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1063110</ArticleId><ArticleId IdType="pmc">PMC9773372</ArticleId><ArticleId IdType="pubmed">36569847</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller Z.A., Rankin K.P., Graff-Radford N.R., Takada L.T., Sturm V.E., Cleveland C.M., Criswell L.A., Jaeger P.A., Stan T., Heggeli K.A. TDP-43 Frontotemporal Lobar Degeneration and Autoimmune Disease. J. Neurol. Neurosurg. Psychiatry. 2013;84:956&#x2013;962. doi: 10.1136/jnnp-2012-304644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304644</ArticleId><ArticleId IdType="pmc">PMC3840954</ArticleId><ArticleId IdType="pubmed">23543794</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller Z.A., Sturm V.E., Camsari G.B., Karydas A., Yokoyama J.S., Grinberg L.T., Boxer A.L., Rosen H.J., Rankin K.P., Gorno-Tempini M.L. Increased Prevalence of Autoimmune Disease within C9 and FTD/MND Cohorts: Completing the Picture. Neurol. -Neuroimmunol. Neuroinflammation. 2016;3:e301. doi: 10.1212/NXI.0000000000000301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000301</ArticleId><ArticleId IdType="pmc">PMC5087253</ArticleId><ArticleId IdType="pubmed">27844039</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail A., Cooper-Knock J., Highley J.R., Milano A., Kirby J., Goodall E., Lowe J., Scott I., Constantinescu C.S., Walters S.J. Concurrence of Multiple Sclerosis and Amyotrophic Lateral Sclerosis in Patients with Hexanucleotide Repeat Expansions of C9ORF72. J. Neurol. Neurosurg. Psychiatry. 2013;84:79&#x2013;87. doi: 10.1136/jnnp-2012-303326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303326</ArticleId><ArticleId IdType="pubmed">23085936</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D., Jin T., Zhu H., Chen H., Ofengeim D., Zou C., Mifflin L., Pan L., Amin P., Li W. TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging. Cell. 2018;174:1477&#x2013;1491. doi: 10.1016/j.cell.2018.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.041</ArticleId><ArticleId IdType="pmc">PMC6128749</ArticleId><ArticleId IdType="pubmed">30146158</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.-J., Hong Y.-H., Kim S.-M., Shin J.-Y., Suh Y.J., Sung J.-J. High Neutrophil-to-Lymphocyte Ratio Predicts Short Survival Duration in Amyotrophic Lateral Sclerosis. Sci. Rep. 2020;10:428. doi: 10.1038/s41598-019-57366-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-57366-y</ArticleId><ArticleId IdType="pmc">PMC6965090</ArticleId><ArticleId IdType="pubmed">31949271</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q.-Q., Hou Y.-B., Zhang L.-Y., Ou R.-W., Cao B., Chen Y.-P., Shang H.-F. Neutrophil-to-Lymphocyte Ratio in Sporadic Amyotrophic Lateral Sclerosis. Neural Regen. Res. 2022;17:875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8530123</ArticleId><ArticleId IdType="pubmed">34472488</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone M.A., Mandrioli J., Russo S., Cucovici A., Gianferrari G., Lisnic V., Muresanu D.F., Giuliani F., Copetti M., Consortium P.R.O.-A.A.L.S.C.T. Neutrophils-to-Lymphocyte Ratio Is Associated with Progression and Overall Survival in Amyotrophic Lateral Sclerosis. Biomedicines. 2022;10:354. doi: 10.3390/biomedicines10020354.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10020354</ArticleId><ArticleId IdType="pmc">PMC8962424</ArticleId><ArticleId IdType="pubmed">35203564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunetta C., Lizio A., Maestri E., Sansone V.A., Mora G., Miller R.G., Appel S.H., Chi&#xf2; A. Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis. JAMA Neurol. 2017;74:660&#x2013;667. doi: 10.1001/jamaneurol.2016.6179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.6179</ArticleId><ArticleId IdType="pmc">PMC5822215</ArticleId><ArticleId IdType="pubmed">28384752</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Zhao W., Neal D.W., Thonhoff J.R., Thome A.D., Faridar A., Wen S., Wang J., Appel S.H. Elevated Acute Phase Proteins Reflect Peripheral Inflammation and Disease Severity in Patients with Amyotrophic Lateral Sclerosis. Sci. Rep. 2020;10:15295. doi: 10.1038/s41598-020-72247-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-72247-5</ArticleId><ArticleId IdType="pmc">PMC7499429</ArticleId><ArticleId IdType="pubmed">32943739</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka H., Shimazawa M., Kimura M., Takata M., Tsuruma K., Yamada M., Takahashi H., Hozumi I., Niwa J., Iguchi Y. The Potential of GPNMB as Novel Neuroprotective Factor in Amyotrophic Lateral Sclerosis. Sci. Rep. 2012;2:573. doi: 10.1038/srep00573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00573</ArticleId><ArticleId IdType="pmc">PMC3417778</ArticleId><ArticleId IdType="pubmed">22891158</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte A., Lattante S., Zollino M., Marangi G., Luigetti M., Del Grande A., Servidei S., Trombetta F., Sabatelli M. P525L FUS Mutation Is Consistently Associated with a Severe Form of Juvenile Amyotrophic Lateral Sclerosis. Neuromuscul. Disord. 2012;22:73&#x2013;75. doi: 10.1016/j.nmd.2011.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2011.08.003</ArticleId><ArticleId IdType="pubmed">21907581</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>